Traws Pharma, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Traws Pharma, Inc. (TRAW) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 38.71 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 8.80M shares, a 23.66% increase year-over-year.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.12M shares, a 6337.42% increase year-over-year.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 110.60K shares, a 94.98% decline year-over-year.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 2.20M shares, a 61.48% increase year-over-year.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.26M shares, a 2.41% decline from fiscal 2024.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 4.36M shares, a 3707.41% increase from fiscal 2023.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 114.64K shares, a 93.42% decline from fiscal 2022.
- Traws Pharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.74M shares, a 84.50% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 38.71M shares 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | 8.80M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 4.26M shares 10-K · filed 2026-04-15 | |||||||
| 2025-09-30 | 7.04M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 6.94M shares 10-Q · filed 2026-08-14 | |||||||
| 2025-03-31 | 7.12M shares 10-Q · filed 2026-05-15 | 6.58M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 4.36M shares 10-K · filed 2026-04-15 | |||||||
| 2024-09-30 | 3.44M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 5.47M shares 10-Q · filed 2025-08-14 | 136.67M shares 10-Q · filed 2024-08-15 | ||||||
| 2024-03-31 | 110.60K shares 10-Q · filed 2025-05-15 | 2.60M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 114.64K shares 10-K · filed 2025-03-31 | 2.62M shares 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | 102.15K shares 10-Q · filed 2024-11-14 | 2.51M shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 2.06M shares 10-Q · filed 2024-08-15 | |||||||
| 2023-03-31 | 2.20M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 1.74M shares 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | 1.67M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 1.34M shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 1.36M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 944.59K shares 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | 934.59K shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 555.23K shares 10-Q · filed 2022-08-15 | 571.63K shares 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | 555.23K shares 10-Q · filed 2022-05-13 | 8.33M shares 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | 731.03K shares 10-K · filed 2022-03-21 | 10.97M shares 10-K · filed 2021-03-18 | ||||||
| 2020-09-30 | 833.02K shares 10-Q · filed 2021-11-15 | 12.50M shares 10-Q · filed 2020-11-16 | ||||||
| 2020-06-30 | 1.53M shares 10-Q · filed 2021-08-16 | 22.91M shares 10-Q · filed 2020-08-12 | ||||||
| 2020-03-31 | 28.39M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 55.60M shares 10-K · filed 2021-03-18 | |||||||
| 2019-09-30 | 6.02M shares 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | 5.86M shares 10-Q · filed 2020-08-12 | |||||||
| 2019-03-31 | 5.85M shares 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | 6.10M shares 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | 6.06M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 5.80M shares 10-Q · filed 2019-08-14 | 86.97M shares 10-Q · filed 2018-08-14 | ||||||
| 2018-03-31 | 1.09M shares 10-Q · filed 2019-05-15 | 16.35M shares 10-Q · filed 2018-05-15 | ||||||
| 2017-12-31 | 4.19M shares 10-K · filed 2019-04-01 | |||||||
| 2017-09-30 | 280.14K shares 10-Q · filed 2018-11-14 | 4.20M shares 10-Q · filed 2017-11-09 | ||||||
| 2017-06-30 | 4.22M shares 10-Q · filed 2018-08-14 | |||||||
| 2017-03-31 | 4.42M shares 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | 4.27M shares 10-K · filed 2018-03-16 | |||||||
| 2016-09-30 | 4.23M shares 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | 667.34K shares 10-Q · filed 2017-08-14 | |||||||
| 2016-03-31 | 663.96K shares 10-Q · filed 2017-05-15 | 6.64M shares 10-Q · filed 2016-05-11 | ||||||
| 2015-12-31 | 516.22K shares 10-K · filed 2017-03-29 | 5.16M shares 10-K · filed 2016-03-28 | ||||||
| 2015-09-30 | 517.12K shares 10-Q · filed 2016-11-14 | 5.17M shares 10-Q · filed 2015-11-12 | ||||||
| 2015-06-30 | 477.12K shares 10-Q · filed 2016-08-15 | 4.77M shares 10-Q · filed 2015-08-13 | ||||||
| 2015-03-31 | 4.57M shares 10-Q · filed 2016-05-11 | |||||||
| 2014-12-31 | 4.64M shares 10-K · filed 2016-03-28 | |||||||
| 2014-09-30 | 4.12M shares 10-Q · filed 2015-11-12 | |||||||
| 2014-06-30 | 4.24M shares 10-Q · filed 2015-08-13 | |||||||
| 2014-03-31 | 4.26M shares 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | 4.35M shares 10-K · filed 2015-03-30 | |||||||
| 2013-09-30 | 3.55M shares 10-Q · filed 2014-11-14 | |||||||
| 2013-06-30 | 15.64M shares 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | 15.63M shares 10-Q · filed 2014-05-15 | |||||||
| 2012-12-31 | 15.41M shares 10-K · filed 2015-03-30 | |||||||
| 2012-09-30 | 14.96M shares 10-Q · filed 2013-11-14 | |||||||
| 2012-06-30 | 10.86M shares 10-Q · filed 2013-09-06 | |||||||
| 2011-12-31 | 11.03M shares 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |